Revolutionizing Cancer & Brain Infection Therapies: VCU, UCLA, Colorado, MD Anderson, MeiraGTx

Researchers from VCU Massey, UCLA Health, and the University of Colorado have developed a platform using patient-derived organoids to test cancer therapies. This method allows real-time monitoring of treatment responses, potentially leading to personalized cancer treatments.

The University of Texas MD Anderson Cancer Center has created a T cell therapy for progressive multifocal leukoencephalopathy, achieving a significant response rate in a Phase Two study. This therapy offers hope for patients with this rare brain infection.

The FDA announced a public hearing on the therapeutic use of psychedelic drugs, scheduled for September 2026. The hearing will gather insights on their potential medical applications.

The Department of Health and Human Services seeks feedback on training models for administering future psychedelic therapies, following an executive order to accelerate mental illness treatments.

MeiraGTx has secured $400 million from Oberland Capital to advance its gene therapy programs. This funding supports the development and commercialization of therapies for unmet medical needs.

Lucid Health Solutions Embedding the patient, caregiver and provider perspective into every decision that shapes health outcomes https://www.lucidhealthsolutions.com

Lucid Health Solutions Embedding the patient, caregiver and provider perspective into every decision that shapes health outcomes https://www.lucidhealthsolutions.com

📚 Sources:

• https://news.vcu.edu/article/new-ai-powered-platform-helps-researchers-find-promising-cancer-therapies-faster
• https://www.mdanderson.org/newsroom/research-newsroom/experimental-cell-therapy-delivers-encouraging-results-for-patients-with-rare-potentially-fatal-brain-infection.h00-159856923.html
• https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for
• https://www.federalregister.gov/documents/2026/07/14/2026-14146/request-for-information-training-and-care-delivery-models-for-safe-administration-of-potential
• https://www.fiercebiotech.com/biotech/meiragtx-scores-400m-oberland-capital-help-get-2-gene-therapies-commercialization

What is NextGen Patient Voice?

NextGen Patient Voice explores how research, AI, and public policy are transforming patient advocacy. Each episode breaks down the ideas, tools, and decisions shaping the future of healthcare, with a focus on what they mean for patients, caregivers, and advocates. Clear, practical, and forward-looking, this podcast connects innovation to real-world patient impact.

[object Object]